Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Loo

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical and Vaccine Immunology : CVI|November 16, 2007
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virusBrian R Long, Jakob Michaelsson, Christopher P Loo, et al.
Scandinavian Journal of Immunology|January 5, 2011
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionC Kuylenstierna, J E Snyder-Cappione, C P Loo, et al.
AIDS (London, England)|July 11, 2009
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expressionJennifer E Snyder-Cappione, Christopher P Loo, Karina I Carvalho, et al.
The Journal of Infectious Diseases|April 3, 2007
Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cellsJennifer E Snyder-Cappione, Douglas F Nixon, Christopher P Loo, et al.
Leukemia|January 21, 2023
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8<sup>+</sup> T cellsKyle A Romine, Kevin MacPherson, Hyun-Jun Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severityWassim M Ballan, Bien-Aimee N Vu, Brian R Long, et al.
Plos One|December 22, 2006
Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removalFatema A Legrand, Douglas F Nixon, Christopher P Loo, et al.
Clinical and Experimental Immunology|September 26, 2009
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological diseaseL C Ndhlovu, J E Snyder-Cappione, K I Carvalho, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 <sup>+</sup> T cell responsesJillian M Jespersen J, Lia Avanesyan, Jean Publicover, et al.
Science Translational Medicine|April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responsesJillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical and Vaccine Immunology : CVI|November 16, 2007
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virusBrian R Long, Jakob Michaelsson, Christopher P Loo, et al.
Scandinavian Journal of Immunology|January 5, 2011
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionC Kuylenstierna, J E Snyder-Cappione, C P Loo, et al.
AIDS (London, England)|July 11, 2009
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expressionJennifer E Snyder-Cappione, Christopher P Loo, Karina I Carvalho, et al.
The Journal of Infectious Diseases|April 3, 2007
Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cellsJennifer E Snyder-Cappione, Douglas F Nixon, Christopher P Loo, et al.
Leukemia|January 21, 2023
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8<sup>+</sup> T cellsKyle A Romine, Kevin MacPherson, Hyun-Jun Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severityWassim M Ballan, Bien-Aimee N Vu, Brian R Long, et al.
Plos One|December 22, 2006
Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removalFatema A Legrand, Douglas F Nixon, Christopher P Loo, et al.
Clinical and Experimental Immunology|September 26, 2009
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological diseaseL C Ndhlovu, J E Snyder-Cappione, K I Carvalho, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 <sup>+</sup> T cell responsesJillian M Jespersen J, Lia Avanesyan, Jean Publicover, et al.
Science Translational Medicine|April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responsesJillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
Pageof 6